Novartis issues a life sciences warning in a 'G-Zero' world Novartis claims life sciences lie at the centre of a shift in geopolitics and policies in regions like Europe, Japan, and Canada are "self-defeating."

#Novartis #lifesciences #PharmaNews #GZero #geopolitics #tariffs #regulation #pharmaceuticalpricing #reimbursement #budgetcaps #clawbacks #Trump #pharmaceuticalmanufacturing #pharmaceuticalRandD #innovativedrugs #medicinesspending #GDP #pharmaceuticalsupplychains #lifescienceshubs
zurl.co/awCLH

Beyond regulation: 4 AI trends transforming life sciences technology in 2026 Artificial intelligence (AI) is becoming embedded into the fabric of quality, compliance, and production systems.

#lifesciences #AI #productionsystems #enterpriseintegration #agenticAI #pharmaceuticalworkflows #pharmaceuticalroboticsmarket #CrossplatformAI #pharmaceuticalmanufacturing #pharmaceuticalsupplychains #lifesciencessoftware #lifesciencessector #lifesciencestechnology
zurl.co/S4rl2

Tariffs 'could cancel out discounts with biosimilars' Tariffs on US pharma imports could remove discounts offered to health systems by biosimilars and threaten the future of the sector, says a non-profit.

#Tariffs #biosimilars #USpharmaimports #BiosimilarsForum #leviesonmedicines #costsavings #referenceproductmedicines #pharmaceuticalsupplychains #pharmaceuticalmanufacturingprocesses #drugshortages #supplychaindisruption #Section232 #biosimilarsupplychain
pharmaphorum.com/news/tariffs...

FTSE 100 pharma giants GSK and Astrazeneca appear to swerve Trump tariffs FTSE 100 giants GSK and AstraZeneca appear to be exempt from higher-rate Trump tariffs according to the City.

#Pharma #Pharmaceuticals #ASTRAZENECA #DONALDTRUMP #EXPORTS #FTSE #FTSE100 #GSK #TARIFFS #PharmaIndustry #pharmagiants #Trumptariffs #Pharmaceuticalgoods #tariffexemption #higherratetariffs #healthcareequity #ReciprocalTariffs #pharmaceuticalsupplychains
www.cityam.com/ftse-100-pha...

China, America and pay inject drama into AstraZeneca’s AGM The boss’s bonus is an annual debating point at Britain’s biggest company. But that’s not the only issue this year

#bigpharma #AstraZeneca #AstraZenecaAGM #PascalSoriot #FTSE100 #UKgovernment #USAtariffs #MichelDemaré #pharmaceuticalsales #respiratory #immunology #newproductlaunches #vaccines #China #UStariffs #pharmaceuticalsupplychains #shareprice #performancetargets
www.theguardian.com/business/202...